Treatment | Dosages (ug/ml) | PL | SVI | ||
---|---|---|---|---|---|
120Â h | 72Â h | 120Â h | 72Â h | ||
No treatment control | 0 | 2.86 ± 0.89 | 2.05 ± 0.71 | 175.3 ± 9.3 | 97.8 ± 8.1 |
Saliva | 150 | 2.09 ± 0.58 | 1.98 ± 0.69 | 106.6 ± 7.81 | 61.38 ± 5.9 |
450 | 1.90 ± 0.33 | 1.81 ± 0.43 | 78.00 ± 6.8 | 42.29 ± 4.3 | |
Hemolymph | 150 | 1.85 ± 0.53 | 1.77 ± 0.60 | 87.00 ± 8.1 | 47.16 ± 6.7 |
450 | 1.76 ± 0.42 | 1.69 ± 0.32 | 52.47 ± 3.8 | 17.74 ± 2.4 | |
Positive control glucantime | 50 | 1.92 ± 0.51 | 1.72 ± 0.38 | 84.21 ± 5.7 | 38.85 ± 4.5 |
100 | 1.69 ± 0.34 | 1.45 ± 0.31 | 53.78 ± 3.5 | 18.82 ± 1.1 |